Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

BLISS GVS PHARMA LTD. - 506197 - Shareholder Meeting / Postal Ballot-Outcome of AGM

 Pursuant to Regulation 30 of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the 34th Annual General Meeting of the Company was held today i.e. Friday, September 20, 2019 at 10.30 a.m. (commenced at 11:00 a.m.) at Hotel The Mirador, New Link Road, Andheri (East), Mumbai-400 099. In this regard, please find attached outcome of Annual General Meeting.
20-09-2019
Bigul

BLISS GVS PHARMA LTD. - 506197 - Intimation Regarding Transfer Of Shares Of The Company Pursuant To The SEBI Circular No. SEBI/HO/MIRSD/DOS3/CIR/P/2018/139 Dated 6Th November, 2018

 Further to our letter dated July 16, 2019 relating to proposed transfer of shares pursuant to the aforesaid SEBI Circular, this is to inform you that the Company has on August 23, 2019 approved the transfer of 1120 shares of the Company as no objection was received by the Company/ RTA for the said transfer. Further, as per the said circular, the shares shall be under lock-in for a period of six months from the date of registration of transfer. The Company has displayed the name of the transferor and the transferee and no. of shares transferred on its website and it shall remain there for a period of six months from the date of the transfer. You are requested to the take the above on your records.
30-08-2019
Bigul

BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 30 and 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the extract of the newspaper advertisement regarding the Notice of 34th Annual General Meeting, Remote E-voting and Book Closure published in the following newspapers on August 28, 2019. a) 'The Free Press Journal' an English Daily and b) 'Navshakti' a Regional Daily.
28-08-2019
Bigul

BLISS GVS PHARMA LTD. - 506197 - Reg. 34 (1) Annual Report

 In terms of Regulation 34 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached 34th Annual Report of Bliss GVS Pharma Limited for the financial year 2018-19. Kindly take the same on record and upload it on your respective website.
27-08-2019
Bigul

BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Investor Presentation

 Enclosed herewith investor presentation on Company's performance for the quarter ended June 30, 2019. Kindly take the same on record.
21-08-2019
Bigul

Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose copies of the newspaper notice published in The Free Press Journal (English) and Navshakti (Regional) newspapers on August 21, 2019 for attention of Shareholders in respect of transfer of unclaimed final dividend and corresponding equity shares of the Company to Investor Education and Protection Fund ("IEPF") for the financial year 2011-2012 in accordance with the provisions of the Companies Act, 2013 read with the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016, as amended from time to time.
21-08-2019
Bigul

Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to the provisions of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the extract copies of newspaper advertisement clippings of unaudited financial results of the Company for the first quarter ended June 30, 2019 published in 'The Economic Times & The Free Press Journal' an English Daily and 'Maharashtra Times & Navshkati' a Regional Daily, on August 14, 2019. Kindly take the same on record.
14-08-2019
Bigul

Bliss GVS Pharma Ltd - 506197 - Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2019

 Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Board Meeting of the Company was held today i.e. on Monday, August 12, 2019 at 11.00 a.m. at the registered office of the Company. The Board has considered and approved the following: 1.The Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2019. 2.Pursuant to the recommendation of the Nomination & Remuneration Committee and subject to approval of the shareholders of the Company at ensuing Annual General Meeting, the Board re-appointed Mr. Mayank Mehta (DIN: 00765052) as Independent Director of the Company for a second term of 5 years with effective from August 28, 2019 (current term expires on August 27, 2019) and not liable to retire by rotation.
12-08-2019
Bigul

BLISS GVS PHARMA LTD. - 506197 - Clarification

 With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Bliss GVS Pharma Ltd has submitted to BSE a copy of Clarification is enclosed.
06-08-2019
Bigul

Bliss GVS Pharma Ltd - 506197 - Clarification sought from Bliss GVS Pharma Ltd

 The Exchange has sought clarification from Bliss GVS Pharma Ltd on August 5, 2019 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.
05-08-2019
Next Page
Close

Let's Open Free Demat Account